Harrow

HROW

Market cap $1.73B

46.78 USD

-4.26

8.35%

At close Updated Jan 9, 4:00 PM EST

Pre-market

After hours

46.90

+0.12

0.26%

1 day

-8.35%

5 days

-8.78%

1 month

-3.29%

3 months

15.31%

6 months

47.76%

Year to date

-6.27%

1 year

27.57%

5 years

495.17%

10 years

652.09%

About: Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.

Employees: 382

Healthcare Drug Manufacturers - Specialty & Generic